Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:29642005  

Mind Bomb Regulates Cell Death during TNF Signaling by Suppressing RIPK1's Cytotoxic Potential.

Rebecca Feltham | Kunzah Jamal | Tencho Tenev | Gianmaria Liccardi | Isabel Jaco | Celia Monteiro Domingues | Otto Morris | Sidonie Wicky John | Alessandro Annibaldi | Marcella Widya | Conor J Kearney | Danielle Clancy | Paul R Elliott | Timo Glatter | Qi Qiao | Andrew J Thompson | Alexey Nesvizhskii | Alexander Schmidt | David Komander | Hao Wu | Seamus Martin | Pascal Meier
Cell reports | 2018

Tumor necrosis factor (TNF) is an inflammatory cytokine that can signal cell survival or cell death. The mechanisms that switch between these distinct outcomes remain poorly defined. Here, we show that the E3 ubiquitin ligase Mind Bomb-2 (MIB2) regulates TNF-induced cell death by inactivating RIPK1 via inhibitory ubiquitylation. Although depletion of MIB2 has little effect on NF-κB activation, it sensitizes cells to RIPK1- and caspase-8-dependent cell death. We find that MIB2 represses the cytotoxic potential of RIPK1 by ubiquitylating lysine residues in the C-terminal portion of RIPK1. Our data suggest that ubiquitin conjugation of RIPK1 interferes with RIPK1 oligomerization and RIPK1-FADD association. Disruption of MIB2-mediated ubiquitylation, either by mutation of MIB2's E3 activity or RIPK1's ubiquitin-acceptor lysines, sensitizes cells to RIPK1-mediated cell death. Together, our findings demonstrate that Mind Bomb E3 ubiquitin ligases can function as additional checkpoint of cytokine-induced cell death, selectively protecting cells from the cytotoxic effects of TNF.

Pubmed ID: 29642005

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R01 AI050872
  • Agency: Medical Research Council, United Kingdom
    Id: MC_U105192732
  • Agency: NCI NIH HHS, United States
    Id: R01 CA126239
  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BB/L021684/1
  • Agency: Medical Research Council, United Kingdom
    Id: MR/M019217/1
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM094231
  • Agency: Worldwide Cancer Research, United Kingdom
    Id: 14-1328
  • Agency: Worldwide Cancer Research, United Kingdom
    Id: 15-0042
  • Agency: Cancer Research UK, United Kingdom
    Id: CRM089X
  • Agency: NIAID NIH HHS, United States
    Id: R37 AI050872
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI045937

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-231 (tool)

RRID:CVCL_0062

Cell line MDA-MB-231 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

Jurkat (tool)

RRID:CVCL_0065

Cell line Jurkat is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HT-1080 (tool)

RRID:CVCL_0317

Cell line HT-1080 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions